-
Novartis AG is a
Swiss multinational pharmaceutical corporation based in Basel, Switzerland.
Novartis is one of the
largest pharmaceutical companies in...
-
AveXis was
acquired by
Novartis in 2018 for USD 8.7 billion. In
September 2020,
Novartis changed the company's name to
Novartis Gene Therapies. In 2019...
-
Prior to
October 2023, it was part of a
division of
Novartis that was
established in 2003, when
Novartis united all of its
generics businesses under the name...
- The
Novartis-Drew
Award for
Biomedical Research is an
award jointly presented by
Novartis and Drew University. It
comprises a cash
award (originally $2000)...
-
acquired the
brand from
Novartis in 2002,
except in the
United States,
where Nestlé
acquired the
rights separately from
Novartis in the late 2000s. Ovaltine...
- In
February 2012,
Novartis Consumer Health announced that they were temporarily,
voluntarily suspending operations at the
Novartis Consumer Health Lincoln...
- The
Novartis Foundation (formerly
known as the
Novartis Foundation for
Sustainable Development) is a non-profit
organization and part of the corporate...
- sold
under the
brand names Gleevec and
Glivec (both
marketed worldwide by
Novartis)
among others, is an oral
targeted therapy medication used to
treat cancer...
- 2008,
Novartis purchased approximately 25% of Nestlé's
stake in Alcon, with an
option to buy Nestlé's
remaining shares beginning in 2010.
Novartis bought...
-
executive officer of
Novartis. He
succeeded Joseph Jimenez who left
Novartis in 2018. He
briefly worked at
McKinsey before joining Novartis in 2005,
where he...
